Literature DB >> 15608421

Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma.

Angela A Chang1, Carter Van Waes.   

Abstract

Head and neck squamous cell carcinomas exhibit alterations in cell proliferation, survival (apoptosis), migration, angiogenesis and inflammation. The transcription factor nuclear factor-KappaB integrates multiple signals and regulates expression of multiple genes involved in these phenotypic responses, suggesting the hypothesis that nuclear factor-KappaB is an important molecular switch for development of head and neck squamous cell carcinoma. Nuclear factor-KappaB has been found to be constitutively activated, and a common target and activator of oncogenes in cancer. Because of its important role, activation of nuclear factor-KappaB by the proteasome and other signal molecules may provide targets for molecular therapy of squamous cell carcinoma and other cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608421     DOI: 10.1159/000082476

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  7 in total

1.  Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor.

Authors:  Jong Myung Kim; Ji Sun Song; Hyun Hwa Cho; Keun Koo Shin; Yong Chan Bae; Byung Ju Lee; Jin Sup Jung
Journal:  Mol Cell Biochem       Date:  2010-10-02       Impact factor: 3.396

2.  Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.

Authors:  Ming Yu; Jason Yeh; Carter Van Waes
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

3.  Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation.

Authors:  Justin G Madson; David T Lynch; Kelsey L Tinkum; Sumanth K Putta; Laura A Hansen
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

4.  Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.

Authors:  Pattatheyil Arun; Matthew S Brown; Reza Ehsanian; Zhong Chen; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

5.  Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells.

Authors:  Myong-Hee Sung; Lorena Bagain; Zhong Chen; Tatiana Karpova; Xinping Yang; Christopher Silvin; Ty C Voss; James G McNally; Carter Van Waes; Gordon L Hager
Journal:  Mol Pharmacol       Date:  2008-08-06       Impact factor: 4.436

6.  Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.

Authors:  Zhipeng Li; Jipei Liao; Zejia Yang; Eun Yong Choi; Rena G Lapidus; Xuefeng Liu; Kevin J Cullen; Hancai Dan
Journal:  Br J Cancer       Date:  2018-12-26       Impact factor: 7.640

7.  USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2.

Authors:  Z Li; Q Hao; J Luo; J Xiong; S Zhang; T Wang; L Bai; W Wang; M Chen; W Wang; L Gu; K Lv; J Chen
Journal:  Oncogene       Date:  2015-09-28       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.